These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Hoang-Xuan K, Taillandier L, Chinot O, Soubeyran P, Bogdhan U, Hildebrand J, Frenay M, De Beule N, Delattre JY, Baron B, European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol; 2003 Jul 15; 21(14):2726-31. PubMed ID: 12860951 [Abstract] [Full Text] [Related]
7. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H, Van't Veer M, Hansen M, Soubeyran P, Taphoorn M, Thomas J, Van den Bent M, Fickers M, Van Imhoff G, Rozewicz C, Teodorovic I, van Glabbeke M, European Organization for Research and Treatment of Cancer Lymphoma Group. J Clin Oncol; 2003 Dec 15; 21(24):4483-8. PubMed ID: 14597741 [Abstract] [Full Text] [Related]
9. Primary CNS lymphoma. Gerstner E, Batchelor T. Expert Rev Anticancer Ther; 2007 May 15; 7(5):689-700. PubMed ID: 17492932 [Abstract] [Full Text] [Related]
10. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U. J Clin Oncol; 2003 Dec 15; 21(24):4489-95. PubMed ID: 14597744 [Abstract] [Full Text] [Related]
11. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up. Omuro AM, DeAngelis LM, Yahalom J, Abrey LE. Neurology; 2005 Jan 11; 64(1):69-74. PubMed ID: 15642906 [Abstract] [Full Text] [Related]
12. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Ilariucci F, Rossi G, Soffietti R, Stelitano C, Vallisa D, Zaja F, Zoppegno L, Aondio GM, Avvisati G, Balzarotti M, Brandes AA, Fajardo J, Gomez H, Guarini A, Pinotti G, Rigacci L, Uhlmann C, Picozzi P, Vezzulli P, Ponzoni M, Zucca E, Caligaris-Cappio F, Cavalli F, International Extranodal Lymphoma Study Group (IELSG). Lancet; 2009 Oct 31; 374(9700):1512-20. PubMed ID: 19767089 [Abstract] [Full Text] [Related]
15. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group. Colombat P, Lemevel A, Bertrand P, Delwail V, Rachieru P, Brion A, Berthou C, Bay JO, Delepine R, Desablens B, Camilleri-Broët S, Linassier C, Lamy T. Bone Marrow Transplant; 2006 Sep 31; 38(6):417-20. PubMed ID: 16951691 [Abstract] [Full Text] [Related]